---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-006138"
form_type: "8-K"
ticker: "GWLL"
cik: "0001800373"
company_name: "GOLDENWELL BIOTECH, INC."
filed_at: "2026-10-09T13:50:45+00:00"
generated_at: "2026-10-12T15:15:32.991919+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Goldenwell Biotech adds Ming Zhou to board; CEO Shuang Liu gifts her 20.2% stake

## Summary
- Board appointed Ming Zhou, 57, as a director on October 8, 2026; board now has four members: Shuang Liu, Yang Lee, Hua Xie and Zhou.
- CEO Shuang Liu gifted 20,000,000 shares to Zhou the same day, equal to roughly 20.2% of Goldenwell's issued and outstanding common stock.
- Zhou has been Managing Director of Get Health Co., Ltd. and Get Intertrading Co., Ltd. in Samutprakan, Thailand since 2021, covering health products, supplements and direct sales.
- Zhou attended China Central Radio and TV University (now Open University of China) from 1991 to 1993, earning an Associate's Degree in Business Administration.
- Company states no family relationships between Zhou and any director or officer, and no related-party transactions involving her since the start of the last fiscal year.

## SEC filing metadata
- accession: 0001477932-26-006138
- form_type: 8-K
- ticker: GWLL
- cik: 0001800373
- company_name: GOLDENWELL BIOTECH, INC.
- filed_at: 2026-10-09T13:50:45+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/0001477932-26-006138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/gdwl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-006138
- JSON: https://secwatch.observer/filing/0001477932-26-006138.json
- Plain text: https://secwatch.observer/filing/0001477932-26-006138.txt

## Key facts
- Executive change
  Ming Zhou was appointed as director at GOLDENWELL BIOTECH, INC..
  - Action: appointed
  - Role: director
  source text: On October 8, 2026, the board of directors of Goldenwell Biotech, Inc. (the “Company”) appointed Ming Zhou as a director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/0001477932-26-006138-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
